Acquired Glanzmann thrombasthenia (GT) is generally caused by anti‐αIIbβ3 autoantibodies. We report the case of a man with an acquired GT phenotype associated with macrothrombocytopenia. Perturbed platelet function were associated with an activating anti‐αIIbβ3 IgM autoantibody. This novel clinical entity raises interesting questions about the αIIbβ3 integrin signaling. Summary BackgroundAcquired Glanzmann thrombasthenia (GT) is a bleeding disorder generally caused by anti‐αIIbβ3 autoantibodies. ObjectivesWe aimed to characterize the molecular mechanism leading to a progressive GT‐like phenotype in a patient with chronic immune thrombocytopenia. Patient, Methods, and ResultsThe patient suffered from repeated episodes of gastrointestinal bleeding; further studies indicated a moderate platelet aggregation defect. A few months later, platelet function showed abolished aggregation using all agonists, but normal agglutination with ristocetin. No platelet‐bound antibodies were detected, but the presence of large amounts of an IgM type antibody detected together with αIIbβ3 in the patient permeabilized platelets suggested that this IgM was an autoantibody causing the internalization of the complex. This was confirmed by the fact that the patient IgM bound to normal platelets but not to platelets from GT type I patients. Moreover, patient′s plasma activated αIIbβ3 on controls’ platelets as evidenced by increased PAC‐1 binding. We also demonstrated that the patient plasma triggered αIIbβ3 outside‐in signaling, as β3 Tyr773 and FAK were phosphorylated, and increased the rate of actin polymerization in resting platelets reflecting an impairment of cytoskeletal reorganization. Because different signs of dysmegakaryopoiesis were also observed in our patient, we evaluated the ability of its serum to impair proplatelets formation and showed that it significantly decreased the number of proplatelet‐bearing megakaryocytes in controls’ bone marrow stem cells culture compared with normal serum. ConclusionsWe present the case of a patient with a progressive and severely perturbed platelet function associated with the presence of an IgM activating autoantibody directed against αIIbβ3.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.